Literature DB >> 23273511

Nanoemulsion nasal adjuvant W₈₀5EC induces dendritic cell engulfment of antigen-primed epithelial cells.

Andrzej Myc1, Jolanta F Kukowska-Latallo, Douglas M Smith, Crystal Passmore, Tiffany Pham, Pamela Wong, Anna U Bielinska, James R Baker.   

Abstract

Nanoemulsions are adjuvants that enhance antigen penetration in the nasal mucosa, increase cellular uptake of antigens by both epithelial dendritic cells, and promote migration of antigen-loaded dendritic cells to regional lymph nodes within a day of vaccine administration. The objective of this study was to determine whether the W(80)5EC nanoemulsion adjuvant enhances immune response not only by direct uptake of antigen by dendritic cells, but also indirectly, by phagocytosis of antigen-primed, apoptotic, epithelial cells. Consistent with this, we show that exposure of both epithelial cells (TC-1s) and dendritic cells (JAWS II or bone marrow derived dendritic cells (BMDCs)) to nanoemulsion exhibited augmented antigen uptake in cell culture. TC-1 cells subsequently underwent G(2)/M cell cycle arrest and apoptosis, and when co-cultured with JAWS II or BMDCs were rapidly engulfed by the dendritic cells, which responded by up-regulating dendritic cell maturation marker CD86. Altogether these results suggest that the effectiveness of nanoemulsions as adjuvants stems, at least in part, from the engulfment of antigen-loaded epithelial cells, leading to enhanced antigen processing and a strong and balanced mucosal and systemic immune response.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273511      PMCID: PMC3556236          DOI: 10.1016/j.vaccine.2012.12.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  54 in total

Review 1.  Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections.

Authors:  G Hajishengallis; S Arce; C M Gockel; T D Connell; M W Russell
Journal:  J Dent Res       Date:  2005-12       Impact factor: 6.116

Review 2.  Targeting the innate immune response with improved vaccine adjuvants.

Authors:  Achal Pashine; Nicholas M Valiante; Jeffrey B Ulmer
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

Review 3.  From TCR engagement to T cell activation: a kinetic view of T cell behavior.

Authors:  A Lanzavecchia; G Iezzi; A Viola
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

4.  TLR ligands differentially affect uptake and presentation of cellular antigens.

Authors:  Markus Michael Weck; Frank Grünebach; Daniela Werth; Christian Sinzger; Anita Bringmann; Peter Brossart
Journal:  Blood       Date:  2007-01-11       Impact factor: 22.113

5.  Enhanced antigen delivery via cell death induced by the vaccine adjuvants.

Authors:  Ya-Wun Yang; Shan-Shan Shen
Journal:  Vaccine       Date:  2007-09-20       Impact factor: 3.641

6.  Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Authors:  Anna U Bielinska; Katarzyna W Janczak; Jeffrey J Landers; Paul Makidon; Laurie E Sower; Johnny W Peterson; James R Baker
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

7.  Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates.

Authors:  Anna U Bielinska; Katarzyna W Janczak; Jeffrey J Landers; David M Markovitz; David C Montefiori; James R Baker
Journal:  AIDS Res Hum Retroviruses       Date:  2008-02       Impact factor: 2.205

8.  A novel, killed-virus nasal vaccinia virus vaccine.

Authors:  Anna U Bielinska; Alexander A Chepurnov; Jeffrey J Landers; Katarzyna W Janczak; Tatiana S Chepurnova; Gary D Luker; James R Baker
Journal:  Clin Vaccine Immunol       Date:  2007-12-05

Review 9.  Proximal effects of Toll-like receptor activation in dendritic cells.

Authors:  Colin Watts; Rossana Zaru; Alan R Prescott; Robert P Wallin; Michele A West
Journal:  Curr Opin Immunol       Date:  2006-12-04       Impact factor: 7.486

10.  Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.

Authors:  M L Albert; S F Pearce; L M Francisco; B Sauter; P Roy; R L Silverstein; N Bhardwaj
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more
  9 in total

1.  Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells.

Authors:  Beata U Orzechowska; Jolanta F Kukowska-Latallo; Alexa D Coulter; Zsuzsanna Szabo; Andrzej Gamian; Andrzej Myc
Journal:  Vaccine       Date:  2015-03-25       Impact factor: 3.641

2.  Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.

Authors:  Anna U Bielinska; Paul E Makidon; Katarzyna W Janczak; Luz P Blanco; Benjamin Swanson; Douglas M Smith; Tiffany Pham; Zsuzsanna Szabo; Jolanta F Kukowska-Latallo; James R Baker
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

3.  Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.

Authors:  Pamela T Wong; Su He Wang; Susan Ciotti; Paul E Makidon; Douglas M Smith; Yongyi Fan; Charles F Schuler; James R Baker
Journal:  Mol Pharm       Date:  2013-12-13       Impact factor: 4.939

4.  Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.

Authors:  Pamela T Wong; Pascale R Leroueil; Douglas M Smith; Susan Ciotti; Anna U Bielinska; Katarzyna W Janczak; Catherine H Mullen; Jeffrey V Groom; Erin M Taylor; Crystal Passmore; Paul E Makidon; Jessica J O'Konek; Andrzej Myc; Tarek Hamouda; James R Baker
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Modified Nanoemulsions with Iron Oxide for Magnetic Resonance Imaging.

Authors:  Yongyi Fan; Rui Guo; Xiangyang Shi; Steven Allen; Zhengyi Cao; James R Baker; Su He Wang
Journal:  Nanomaterials (Basel)       Date:  2016-11-25       Impact factor: 5.076

Review 6.  Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.

Authors:  Cynthia Calzas; Christophe Chevalier
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

7.  Silicone Oil-Based Nanoadjuvants as Candidates for a New Formulation of Intranasal Vaccines.

Authors:  Agnieszka Razim; Marcelina Pyclik; Katarzyna Pacyga; Sabina Górska; Jintao Xu; Michal A Olszewski; Andrzej Gamian; Andrzej Myc
Journal:  Vaccines (Basel)       Date:  2021-03-08

8.  A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine.

Authors:  Sonia Jangra; Jeffrey J Landers; Raveen Rathnasinghe; Jessica J O'Konek; Katarzyna W Janczak; Marilia Cascalho; Andrew A Kennedy; Andrew W Tai; James R Baker; Michael Schotsaert; Pamela T Wong
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 8.786

9.  Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens.

Authors:  Brandi T Johnson-Weaver; Hae Woong Choi; Hang Yang; Josh A Granek; Cliburn Chan; Soman N Abraham; Herman F Staats
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.